Evidence for a role of hepatitis virus B in chronic alcoholic liver disease

Comparison of salivary and serum enzyme immunoassays for the diagnosis of Helicobacter pylori infection.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012

Relationship between mucosal levels of interleukin 8 and toxinogenicity of Helicobacter pylori.

Inflammopharmacology·2007

Effects of jet quenching on the hydrodynamical evolution of quark-gluon plasma.

Physical review letters·2006

J/psi suppression in Pb + Pb collisions: a conventional description.

Physical review letters·2002

Normal values for phrenic nerve latency in children.

Muscle & nerve·2001

The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Paired biopsy-surface and tissue microbiome profiling reveals tissue-associated bacterial signatures in nasopharyngeal carcinoma.

Frontiers in cellular and infection microbiology·2026

Nrf2 Activation Induces Fibroblast Senescence and Promotes Melanosome Accumulation in a Fibroblast-Keratinocyte Co-Culture Model.

Biomolecules & therapeutics·2026

Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and Care.

Clinical transplantation·2026

Lymphangioleiomyomatosis (LAM): From Genetics to Management.

Seminars in respiratory and critical care medicine·2026

Cell and Gene Therapy in Lung Transplantation: From Experimental Promise towards Clinical Translation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Occupational Genotoxic Risk in Jewelry Workshop Employees: Evidence from Buccal Cytome and Repair Index Analyses.

Environmental toxicology and pharmacology·2026

Evidence for a role of hepatitis virus B in chronic alcoholic liver disease

Related Experiment Videos

Related Concept Videos

Comparison of salivary and serum enzyme immunoassays for the diagnosis of Helicobacter pylori infection.

Relationship between mucosal levels of interleukin 8 and toxinogenicity of Helicobacter pylori.

Effects of jet quenching on the hydrodynamical evolution of quark-gluon plasma.

J/psi suppression in Pb + Pb collisions: a conventional description.

Normal values for phrenic nerve latency in children.

The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Paired biopsy-surface and tissue microbiome profiling reveals tissue-associated bacterial signatures in nasopharyngeal carcinoma.

Nrf2 Activation Induces Fibroblast Senescence and Promotes Melanosome Accumulation in a Fibroblast-Keratinocyte Co-Culture Model.

Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and Care.

Lymphangioleiomyomatosis (LAM): From Genetics to Management.

Cell and Gene Therapy in Lung Transplantation: From Experimental Promise towards Clinical Translation.

Occupational Genotoxic Risk in Jewelry Workshop Employees: Evidence from Buccal Cytome and Repair Index Analyses.

Evidence for a role of hepatitis virus B in chronic alcoholic liver disease

Related Experiment Videos

Related Concept Videos

Related Articles